#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranoproliferative Obliterative bronchiolitis Sjogren's syndrome Chronic lymphocytic leukaemia refractory Chronic cutaneous lupus erythematosus Duchenne muscular dystrophy gene carrier Small cell lung cancer extensive stage Polycythaemia vera Non-Hodgkin's lymphoma refractory Choroidal dystrophy Acute promyelocytic leukaemia Myasthenia gravis Neoplasm Stargardt's disease Acute graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Optic glioma – Diagnostics Hereditary ataxia Hereditary hypophosphataemic rickets – Diagnostics Antisynthetase syndrome – Diagnostics Undifferentiated sarcoma – Basic Information Thrombotic thrombocytopenic purpura – Treatment Congenital hypotransferrinaemia – Life with Disease Toxic epidermal necrolysis – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Familial haemophagocytic lymphohistiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    M2Rlab HYDROGEN Sodium Nitrite Tolcapone Obexelimab Specific Nucleic Acid Sna-Xfsc Haloperidol Decanoate Tedizolid Phosphate Eight Treg Balcinrenone Gozetotide Alf-18 Dacarbazine Citrate Adenosine GSKVX000000030810 Trimetazidine Dihydrochloride Dirocaftor Cefoxitin Sodium Abiraterone Acetate Vrdn-001 Gozetotide More therapies…

    Learn about Your Condition

    Ewing's sarcoma Thrombosis prophylaxis Vulvovaginal pruritus Mitral valve disease Papillary thyroid cancer Langerhans cell sarcoma Obsessive-compulsive disorder Tertiary adrenal insufficiency Intestinal obstruction Congenital aplastic anaemia Psychotic disorder Neurogenic bladder Osteopenia Klinefelter's syndrome Heart transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Orszagos Onkologiai Intezet

Orszagos Onkologiai Intezet

Rath Gyorgy Utca 7-9, Kerulet, Budapest, 1122, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Cisplatin
    • Fluorouracil
    Denmark France Hungary Italy Romania Spain

  • Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    France Hungary Italy Poland Spain

  • Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Quavonlimab
    • Belzutifan
    • Lenvatinib
    Croatia Czechia Denmark Finland France Germany +8

  • Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    • Dostarlimab
    • Pembrolizumab
    Belgium Bulgaria Croatia Czechia Estonia Finland +14

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Abemaciclib
    • Letrozole
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Abemaciclib
    • Fulvestrant
    Belgium Czechia Denmark France Greece Hungary +3

  • Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Favezelimab
    • Mk-4830
    France Hungary The Netherlands Poland Spain

  • Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Vinorelbine
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Austria Czechia France Germany Hungary Ireland +5

  • Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Gemcitabine
    France Germany Hungary Ireland Poland Spain
Previous Page
1 … 15 16 17

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!